Loading clinical trials...

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT01416116

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

The Summary of product characteristics (SmPC) for QUTENZA advises that topical anaesthetic is applied prior to the application of QUTENZA. This is a multi-center, randomized, assessor-blinded study wh...

Lead sponsor: Astellas Pharma Inc•20 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment122

Start dateJul 2011

Last updatedApr 23, 2018

Condition

or Peripheral Nerve Injury (PNI)

Locations shown

Site 102

Antwerp

Site 103

Genk

Site 101

Roeselare

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 23, 2018Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions